LONDON - Cambridge Cognition Holdings (LON:COGC) PLC (AIM: COG), a developer of digital brain health assessment tools, has announced the expansion of its services with the introduction of an in ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor ...

Cambridge Cognition Holdings PLC Annual stock financials by MarketWatch. View the latest COG financial statements, income statements and financial ratios.

(Alliance News) - Cambridge Cognition Holdings PLC said Wednesday it expects to report a widened annual loss on lower revenue, as a result of declining sales from its core business. Cambridge ...

Cambridge Cognition Holdings' (LON:COG) stock is up by a considerable 33% over the past month. Given that stock prices are usually aligned with a company's financial performance in the long-term ...

Cambridge Cognition Holdings (GB:COG) has released an update.Cambridge Cognition’s spin-out company, Monument Therapeutics, has secured a £1.0 million investment to advance its novel ...

Wauwasota, WI, and Cambridge, UK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Splash Clinical, the new standard in patient recruitment solutions, and Cambridge Cognition (AIM: COG), a leading provider of ...

Cambridge Cognition Holdings PLC, a technology firm specializing in digital brain health assessments, has successfully completed a fundraising initiative, raising approximately £2.6 million ...

Cambridge Cognition establishes a Scientific Advisory Board comprising experts in cognitive science and clinical trials to guide the integration of emerging trends like blood-based biomarkers and ...

Cambridge Cognition has praised Bristol Myers Squibb for the FDA approval of Cobenfy (KarXT), a new treatment for schizophrenia. Recent research published in The American Journal of Psychiatry ...

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce that Monument Therapeutics Limited (“Monument”) a precision ...

Proactive Investors - Cambridge Cognition Holdings PLC (LON:COGC) said revenues for the year just gone were ahead of expectations while it also expects to book a modest underlying profit. In a trading ...